{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:21:09Z","timestamp":1780435269152,"version":"3.54.1"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:00:00Z","timestamp":1496102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundo de Amparo \u00e0 Pesquisa do Rio de Janeiro"},{"name":"Fundo de Amparo \u00e0 Pesquisa do Rio de Janeiro"},{"name":"Fundo de Amparo \u00e0 Pesquisa do Rio de Janeiro"},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178592","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T17:45:09Z","timestamp":1496166309000},"page":"e0178592","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0951-2849","authenticated-orcid":true,"given":"Mauricio Naoto","family":"Saheki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Rosandiski","family":"Lyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro Javier","family":"Bedoya-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliane de F\u00e1tima","family":"Ant\u00f4nio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria In\u00eas Fernandes","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza de Matos","family":"Salgueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rica de Camargo Ferreira e","family":"Vasconcellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Regina Lambert","family":"Passos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginelza Peres Lima dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon Novato","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Fagundes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de F\u00e1tima","family":"Madeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliame","family":"Mouta-Confort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro C\u00e9lio de Almeida","family":"Marzochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia Maria","family":"Valete-Rosalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando de Oliveira","family":"Schubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"ref1","first-page":"697","article-title":"Din\u00e2mica das doen\u00e7as infecciosas e parasit\u00e1rias","author":"AM Da-Cruz","year":"2005"},{"issue":"Suppl 1","key":"ref2","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jinf.2014.07.016","article-title":"Leishmaniasis","volume":"69","author":"D Pace","year":"2014","journal-title":"J Infect"},{"key":"ref3","first-page":"521","article-title":"Leishmanioses do Continente Americano","author":"F Concei\u00e7\u00e3o-Silva","year":"2014"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"J Alvar","year":"2006","journal-title":"Trends Parasitol"},{"key":"ref5","unstructured":"WHO Expert Committee on the Control of the Leishmaniases., World Health Organization. Control of the leishmaniases: report of a meeting of the WHO Expert Commitee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010. Geneva: World Health Organization; 2010. xiii, 186 p."},{"issue":"22","key":"ref6","first-page":"287","article-title":"Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014","volume":"91","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"ref7","unstructured":"Rabello E. Les origines de la leishmaniose t\u00e9gumentaire au Br\u00e9sil. Congr\u00e8s des dermatologistes et syphiligraphes de langue fran\u00e7aise; Juillet 1923; Strasbourg, France;1923."},{"key":"ref8","unstructured":"Rabello E. Formes cliniques de la leishmaniose t\u00e9gumentaire. Congr\u00e8s de dermatologistes et syphiligraphes de langue fran\u00e7aise; Juillet 1923; Strasbourg, France;1923."},{"key":"ref9","unstructured":"Brazil Ministry of Health. Indicadores e dados b\u00e1sicos: taxa de incid\u00eancia da leishmaniose tegumentar americana 2013 [5 June 2013]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dtr2004.saude.gov.br\/sinanweb\/tabnet\/tabnet?sinannet\/lta\/bases\/ltabrnet.def\" xlink:type=\"simple\">http:\/\/dtr2004.saude.gov.br\/sinanweb\/tabnet\/tabnet?sinannet\/lta\/bases\/ltabrnet.def<\/ext-link>."},{"key":"ref10","unstructured":"World Health Organization. Control of the Leishmaniases: report of a meeting of the WHO Expert Committee. Geneva, Switzerland: World Health Organization; 2010. 186 p."},{"key":"ref11","first-page":"426","article-title":"Tratamento da leishmaniose tegumentar por inje\u00e7\u00f5es intravenosas de t\u00e1rtaro em\u00e9tico","volume":"4","author":"G Vianna","year":"1912","journal-title":"Arq Bras Med"},{"key":"ref12","first-page":"180","article-title":"Manual de Vigil\u00e2ncia da Leishmaniose Tegumentar Americana","year":"2010"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/AAC.39.6.1234","article-title":"In vitro antileishmanial properties of tri- and pentavalent antimonial preparations","volume":"39","author":"WL Roberts","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1590\/0037-8682-0104-2013","article-title":"Treatment of American tegumentary leishmaniasis in special populations: a summary of evidence","volume":"46","author":"JS Fontenele e Silva","year":"2013","journal-title":"Rev Soc Bras Med Trop"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1590\/S0037-86822005000300001","article-title":"Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate","volume":"38","author":"O Schubach Ade","year":"2005","journal-title":"Rev Soc Bras Med Trop"},{"issue":"6","key":"ref16","first-page":"496","article-title":"Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg\/kg\/day) and high dosage (20 mg\/kg\/day) antimony regimens","volume":"45","author":"MP Oliveira-Neto","year":"1997","journal-title":"Pathol Biol (Paris)"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4269\/ajtmh.1997.57.651","article-title":"A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years)","volume":"57","author":"MP Oliveira-Neto","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-4362.1997.00188.x","article-title":"Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil\u2014an area of Leishmania (V.) braziliensis transmission","volume":"36","author":"MP Oliveira-Neto","year":"1997","journal-title":"Int J Dermatol"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1590\/S0036-46652000000600004","article-title":"Mucosal leishmaniasis (&quot;espundia&quot;) responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil","volume":"42","author":"MP Oliveira-Neto","year":"2000","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/S0074-02761996000200016","article-title":"High and low doses of antimony (Sbv) in American cutaneous leishmaniasis. A five years follow-up study of 15 patients","volume":"91","author":"MP Oliveira Neto","year":"1996","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1532-5415.2010.02747.x","article-title":"American tegumentary leishmaniasis in older adults: 44 cases treated with an intermittent low-dose antimonial schedule in Rio de Janeiro, Brazil","volume":"58","author":"EVE de Camargo Ferreira","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1590\/S0037-86821988000200013","article-title":"Low dose glucantime therapy in Leishmania viannia braziliensis (Lvb) infections","volume":"21","author":"JM Costa","year":"1988","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"ref23","first-page":"221","article-title":"[A case of mucocutaneous leishmaniasis treated with success with a low dose of pentavalent antimonial]","volume":"31","author":"VS Amato","year":"1998","journal-title":"Rev Soc Bras Med Trop"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1590\/S0037-86822006000400011","article-title":"Successful therapeutic response of resistant cases of mucocutaneous leishmaniasis to a very low dose of antimony","volume":"39","author":"MP de Oliveira-Neto","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"e2130","DOI":"10.1371\/journal.pntd.0002130","article-title":"Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis","volume":"7","author":"P Olliaro","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref26","unstructured":"Ampuero JS. Efficacy and safety of low-dose pentavalent antimonial for treatment of cutaneous leishmaniasis by Leishmania (Viannia) braziliensis in Bahia, Brazil: a randomized clinical trial [Doctoral thesis]. Bras\u00edlia, DF: Universidade de Bras\u00edlia; 2009."},{"key":"ref27","unstructured":"Division of AIDS, National Institute of Allergy Infectious Diseases, National Institutes of Health. Division of AIDS table for grading the severity of adult and pediatric adverse events 2004 [12 May 2015]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/rsc.tech-res.com\/Document\/safetyandpharmacovigilance\/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf\" xlink:type=\"simple\">http:\/\/rsc.tech-res.com\/Document\/safetyandpharmacovigilance\/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf<\/ext-link>."},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"TR Navin","year":"1992","journal-title":"J Infect Dis"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.1990.42.43","article-title":"Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala","volume":"42","author":"TR Navin","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","unstructured":"Mattos MdS. Determina\u00e7\u00e3o de par\u00e2metros cl\u00ednicos e progn\u00f3sticos para o controle de cura da Leishmaniose Tegumentar Americana [Doctoral thesis]. Rio de Janeiro, RJ: Funda\u00e7\u00e3o Oswaldo Cruz; 2004."},{"key":"ref31","first-page":"63","article-title":"Guidance for Industry: non-Inferiority clinical trials","year":"2010"},{"key":"ref32","first-page":"634","article-title":"Applied life data analysis","volume":"xiv","author":"W Nelson","year":"1982"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1994.50.296","article-title":"A general classification of New World Leishmania using numerical zymotaxonomy","volume":"50","author":"E Cupolillo","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"ref34","unstructured":"Antonio LdF. Resposta \u00e0 Intradermorrea\u00e7\u00e3o de Montenegro e ocorr\u00eancia de falha terap\u00eautica na forma cut\u00e2nea da leishmaniose tegumentar americana: um estudo de caso controle [Master&apos;s dissertation]. Rio de Janeiro, RJ: Funda\u00e7\u00e3o Oswaldo Cruz; 2012."},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1258\/td.2008.080369","article-title":"Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil","volume":"39","author":"AL Oliveira","year":"2009","journal-title":"Trop Doct"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"LF Oliveira","year":"2011","journal-title":"Acta Trop"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.3390\/ijerph7124267","article-title":"Antimony toxicity","volume":"7","author":"S Sundar","year":"2010","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)","volume":"34","author":"JD Chulay","year":"1985","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1365-3156.2009.02408.x","article-title":"Antimony in plasma and skin of patients with cutaneous leishmaniasis\u2014relationship with side effects after treatment with meglumine antimoniate","volume":"14","author":"DB Neves","year":"2009","journal-title":"Trop Med Int Health"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1590\/S0037-86822012000500011","article-title":"The effect of age on the frequency of adverse reactions caused by antimony in the treatment of American tegumentary leishmaniasis in Governador Valadares, State of Minas Gerais, Brazil","volume":"45","author":"DS Diniz","year":"2012","journal-title":"Rev Soc Bras Med Trop"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2307\/3282713","article-title":"Metastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters","volume":"77","author":"JE Martinez","year":"1991","journal-title":"J Parasitol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: Newer developments","volume":"4","author":"S Mohapatra","year":"2014","journal-title":"Trop Parasitol"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1128\/AAC.00858-09","article-title":"Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta)","volume":"54","author":"G Grimaldi Jr.","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","article-title":"Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil","volume":"84","author":"A Chrusciak-Talhari","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1371\/journal.pntd.0000912","article-title":"Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial","volume":"4","author":"PR Machado","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref46","unstructured":"Drugs for Neglected Diseases initiative (DNDi). Leishmaniasis factsheet 2015 [cited 2016 November 6, 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.dndi.org\/wp-content\/uploads\/2016\/10\/Factsheet_2015_Leish.pdf\" xlink:type=\"simple\">http:\/\/www.dndi.org\/wp-content\/uploads\/2016\/10\/Factsheet_2015_Leish.pdf<\/ext-link>."},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"e0122569","DOI":"10.1371\/journal.pone.0122569","article-title":"Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials","volume":"10","author":"JA Cardona-Arias","year":"2015","journal-title":"PLoS One"},{"issue":"9185","key":"ref48","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"BL Herwaldt","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis","volume":"4","author":"J Blum","year":"2012","journal-title":"Int Health"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0035-9203(86)90243-9","article-title":"Mucosal leishmaniasis (&quot;espundia&quot; Escomel, 1911)","volume":"80","author":"PD Marsden","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref51","unstructured":"Brahim-Paes LRdN. Distribui\u00e7\u00e3o espa\u00e7otemporal dos casos humanos de leishmaniose tegumentar americana notificados no estado do Rio de Janeiro de 2001 a 2013 e associa\u00e7\u00e3o com vari\u00e1veis cl\u00ednicas e populacionais [Doctoral thesis]. Rio de Janeiro, RJ: Funda\u00e7\u00e3o Oswaldo Cruz; 2016."},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"e0004178","DOI":"10.1371\/journal.pntd.0004178","article-title":"The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy","volume":"9","author":"I Lakhal-Naouar","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1503\/cmaj.091481","article-title":"Is bigger better? An argument for very low starting doses","volume":"183","author":"JP McCormack","year":"2011","journal-title":"CMAJ"},{"key":"ref54","first-page":"181","article-title":"Principles and Practice of Clinical Trial Medicine","author":"R Chin","year":"1996"},{"key":"ref55","first-page":"209","article-title":"Using cost-effectiveness analysis to improve health care: opportunities and barriers","volume":"xii","author":"PJ Neumann","year":"2005"},{"key":"ref56","first-page":"318","article-title":"Making choices in health: WHO guide to cost-effectiveness analysis","author":"RMPM Baltussen","year":"2003"},{"key":"ref57","article-title":"Leishmaniose tegumentar americana: investiga\u00e7\u00e3o SINAN-NET 10.05.2012","year":"2012"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1645\/GE-1031R.1","article-title":"Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis","volume":"93","author":"RB Azeredo-Coutinho","year":"2007","journal-title":"J Parasitol"},{"issue":"8","key":"ref59","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/507710","article-title":"American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?","volume":"194","author":"V Yardley","year":"2006","journal-title":"J Infect Dis"},{"issue":"2","key":"ref60","first-page":"CD004834","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis","author":"U Gonzalez","year":"2009","journal-title":"Cochrane Database Syst Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T08:23:12Z","timestamp":1589012592000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178592"}},"subtitle":[],"editor":[{"given":"Aric","family":"Gregson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178592","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,30]]}}}